547 related articles for article (PubMed ID: 18445767)
1. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease.
Du Y; Zhang X; Tao Q; Chen S; Le W
Neurodegener Dis; 2013; 11(3):113-28. PubMed ID: 22626907
[TBL] [Abstract][Full Text] [Related]
4. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
Zhu W; Li X; Xie W; Luo F; Kaur D; Andersen JK; Jankovic J; Le W
Neurobiol Dis; 2010 Feb; 37(2):307-13. PubMed ID: 19818853
[TBL] [Abstract][Full Text] [Related]
5. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
Zhang X; Xie W; Qu S; Pan T; Wang X; Le W
Biochem Biophys Res Commun; 2005 Jul; 333(2):544-9. PubMed ID: 15950935
[TBL] [Abstract][Full Text] [Related]
7. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death.
Onyango IG; Tuttle JB; Bennett JP
Neurobiol Dis; 2005 Oct; 20(1):141-54. PubMed ID: 16137575
[TBL] [Abstract][Full Text] [Related]
9. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
10. Glial-derived neurotrophic factor (GDNF) prevents ethanol (EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK signaling pathways.
Villegas SN; Njaine B; Linden R; Carri NG
Brain Res Bull; 2006 Dec; 71(1-3):116-26. PubMed ID: 17113937
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
12. GDNF prevents TGF-beta-induced damage of the plasma membrane in cerebellar granule neurons by suppressing activation of p38-MAPK via the phosphatidylinositol 3-kinase pathway.
Subramaniam S; Strelau J; Unsicker K
Cell Tissue Res; 2008 Feb; 331(2):373-83. PubMed ID: 18071753
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
Mandel RJ; Snyder RO; Leff SE
Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
Li X; Yang D; Li L; Peng C; Chen S; Le W
Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
[TBL] [Abstract][Full Text] [Related]
15. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
Zhu W; Xie W; Pan T; Xu P; Fridkin M; Zheng H; Jankovic J; Youdim MB; Le W
FASEB J; 2007 Dec; 21(14):3835-44. PubMed ID: 17690154
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
17. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
18. The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats.
Cao JP; Wang HJ; Yu JK; Liu HM; Gao DS
Brain Res Bull; 2008 Jul; 76(5):505-11. PubMed ID: 18534259
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
Piltonen M; Bespalov MM; Ervasti D; Matilainen T; Sidorova YA; Rauvala H; Saarma M; Männistö PT
Exp Neurol; 2009 Oct; 219(2):499-506. PubMed ID: 19615368
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2.
Chao CC; Chiang CH; Ma YL; Lee EH
Neurobiol Aging; 2006 Jan; 27(1):105-18. PubMed ID: 16298246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
